KBC Group NV raised its position in AMETEK, Inc. (NYSE:AME - Free Report) by 7.4% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 280,571 shares of the technology company's stock after acquiring an additional 19,365 shares during the period. KBC Group NV owned about 0.12% of AMETEK worth $48,297,000 as of its most recent SEC filing.
A number of other hedge funds also recently modified their holdings of AME. Banque Transatlantique SA acquired a new position in shares of AMETEK in the fourth quarter valued at $37,000. OFI Invest Asset Management acquired a new position in shares of AMETEK in the 4th quarter valued at $43,000. Minot DeBlois Advisors LLC bought a new position in shares of AMETEK during the 4th quarter worth about $43,000. Golden State Wealth Management LLC boosted its position in shares of AMETEK by 201.0% during the 1st quarter. Golden State Wealth Management LLC now owns 295 shares of the technology company's stock valued at $51,000 after acquiring an additional 197 shares in the last quarter. Finally, Ancora Advisors LLC increased its stake in AMETEK by 15,950.0% in the fourth quarter. Ancora Advisors LLC now owns 321 shares of the technology company's stock valued at $58,000 after acquiring an additional 319 shares during the period. Institutional investors own 87.43% of the company's stock.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on the company. Morgan Stanley started coverage on AMETEK in a report on Monday, April 14th. They set an "equal weight" rating and a $170.00 price objective on the stock. Royal Bank Of Canada raised their target price on AMETEK from $194.00 to $201.00 and gave the stock an "outperform" rating in a research report on Friday, May 2nd. Robert W. Baird lowered their price target on AMETEK from $197.00 to $190.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 7th. Mizuho set a $212.00 price objective on AMETEK in a report on Friday, May 16th. Finally, Truist Financial upped their target price on shares of AMETEK from $196.00 to $200.00 and gave the stock a "buy" rating in a report on Monday, May 5th. One research analyst has rated the stock with a sell rating, three have given a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $197.89.
Get Our Latest Stock Report on AME
AMETEK Price Performance
Shares of AMETEK stock traded up $2.20 during trading on Thursday, reaching $184.19. The company's stock had a trading volume of 719,336 shares, compared to its average volume of 1,372,172. The stock has a 50-day moving average price of $176.62 and a two-hundred day moving average price of $177.13. The stock has a market capitalization of $42.53 billion, a P/E ratio of 30.15, a price-to-earnings-growth ratio of 2.74 and a beta of 1.09. The company has a current ratio of 1.41, a quick ratio of 0.86 and a debt-to-equity ratio of 0.15. AMETEK, Inc. has a one year low of $145.02 and a one year high of $198.33.
AMETEK (NYSE:AME - Get Free Report) last announced its earnings results on Thursday, May 1st. The technology company reported $1.75 earnings per share for the quarter, topping analysts' consensus estimates of $1.69 by $0.06. AMETEK had a net margin of 20.43% and a return on equity of 16.75%. The company had revenue of $1.73 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same period in the previous year, the firm posted $1.64 earnings per share. The company's revenue was down .2% on a year-over-year basis. As a group, sell-side analysts anticipate that AMETEK, Inc. will post 7.15 EPS for the current fiscal year.
AMETEK Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Friday, June 13th were paid a $0.31 dividend. The ex-dividend date was Friday, June 13th. This represents a $1.24 annualized dividend and a dividend yield of 0.67%. AMETEK's dividend payout ratio (DPR) is currently 20.29%.
AMETEK Profile
(
Free Report)
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
See Also

Before you consider AMETEK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.
While AMETEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.